Cite
A multipeptide vaccine plus toll-like receptor agonists LPS or polyICLC in combination with incomplete Freund's adjuvant in melanoma patients.
MLA
Melssen, Marit M., et al. “A Multipeptide Vaccine plus Toll-like Receptor Agonists LPS or PolyICLC in Combination with Incomplete Freund’s Adjuvant in Melanoma Patients.” Journal for ImmunoTherapy of Cancer, vol. 7, no. 1, Dec. 2019, pp. 1–12. EBSCOhost, https://doi.org/10.1186/s40425-019-0625-x.
APA
Melssen, M. M., Petroni, G. R., Chianese-Bullock, K. A., Wages, N. A., Grosh, W. W., Varhegyi, N., Smolkin, M. E., Smith, K. T., Galeassi, N. V., Deacon, D. H., Gaughan, E. M., & Slingluff Jr, C. L. (2019). A multipeptide vaccine plus toll-like receptor agonists LPS or polyICLC in combination with incomplete Freund’s adjuvant in melanoma patients. Journal for ImmunoTherapy of Cancer, 7(1), 1–12. https://doi.org/10.1186/s40425-019-0625-x
Chicago
Melssen, Marit M., Gina R. Petroni, Kimberly A. Chianese-Bullock, Nolan A. Wages, William W. Grosh, Nikole Varhegyi, Mark E. Smolkin, et al. 2019. “A Multipeptide Vaccine plus Toll-like Receptor Agonists LPS or PolyICLC in Combination with Incomplete Freund’s Adjuvant in Melanoma Patients.” Journal for ImmunoTherapy of Cancer 7 (1): 1–12. doi:10.1186/s40425-019-0625-x.